Kelli Brumley, in Idabel, OK - Counselor

Kelli Brumley, is a Counselor based in Idabel, Oklahoma. Kelli Brumley is licensed to practice in * (Not Available) (license number ) and her current practice location is 411 S Central Ave, Idabel, Oklahoma. She can be reached at her office (for appointments etc.) via phone at (580) 286-5045.

NPI number for Kelli Brumley is 1679711196 and her current mailing address is Po Box 1030, Antlers, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1679711196.

Contact Information

	Kelli Brumley,
	411 S Central Ave, Idabel, OK 74745-6059
	(580) 286-5045
	Not Available

Healthcare Provider's Profile

Full Name	Kelli Brumley
Gender	Female
Speciality	Counselor
Location	411 S Central Ave, Idabel, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1679711196
Provider Enumeration Date: 01/22/2009
Last Update Date: 06/05/2012

Medical Identifiers

Medical identifiers for Kelli Brumley such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1679711196	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TR0400X	Psychologist - Rehabilitation	(* (Not Available))	Secondary
171M00000X	Case Manager/care Coordinator	(* (Not Available))	Secondary
101Y00000X	Counselor	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kelli Brumley is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kelli Brumley, Po Box 1030, Antlers, OK 74523-1030 Ph: (580) 298-2830	Kelli Brumley, 411 S Central Ave, Idabel, OK 74745-6059 Ph: (580) 286-5045

News Archive

Anti-clotting drug may cause problems for elderly trauma patients: Study

A common drug used for preventing heart attacks and blood clots may also cause problems for individuals who suffer some form of trauma, particularly elderly patients, according to a study presented today at the 2009 Clinical Congress of the American College of Surgeons.

Amorcyte receives patent for chemotactic hematopoietic stem cell product

Amorcyte, Inc., a biopharmaceutical company developing cell therapy products to treat cardiovascular disease, today announced that it has been granted United States Patent number 7,794,705 titled "Compositions and Methods of Vascular Injury Repair." The patent contains both composition of matter and method claims surrounding therapeutic chemotactic hematopoietic stem cell products used in treating or repairing a vascular injury following an acute myocardial infarction (AMI), and delivery of the cell therapy.

Common tapeworm drug effectively treats MRSA superbugs in lab

A new study provides evidence from lab experiments that a drug already used in people to fight tapeworms might also prove effective against strains of the superbug MRSA, which kills thousands of people a year in the United States.

Brain imaging studies can provide biomarkers for depression diagnosis: Study

Depression, known to be a condition with impaired psychosocial functioning that severely impacts the quality of life of patients and families, is actually defined with specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks. At least 40% of depressed patients actually benefit from an antidepressant treatment, whereas 20-30% of patients may suffer from chronic depression that negatively impacts their quality of life. In order to improve the efficiency of treatment and reduce the burden of depressive disorders, depression needs to be defined at the neurobiological level.

Kelli Brumley, - in Idabel, OK